CTAS Stock Analysis: Cintas | NASDAQ
Specialty Business Services | NASDAQ, USA | Market Cap: 78.146m USD | 12M Return: -3.9% | US1729081059 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 396M
EPS Trend: -64.7%
Qual. Beats: 1
Rev. Trend: 99.9%
Qual. Beats: 5
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Cintas Corporation (NASDAQ: CTAS) is a business services company that provides corporate identity uniforms and related products, operating across the United States, Canada, and Latin America. The company runs through three segments: Uniform Rental and Facility Services, First Aid and Safety Services, and All Other.
Its offerings include rental and servicing of uniforms, flame-resistant clothing, mats, mops, shop towels, and restroom cleaning supplies, as well as first aid and safety products, workplace water services, and fire protection solutions such as AEDs, extinguishers, sprinkler systems, and alarm services. Cintas distributes through its own network, local delivery routes, and local representatives, serving small and mid-sized businesses, major corporations, and a broad range of industries including gaming, hospitality, healthcare, automotive, government, education, pharmaceutical, manufacturing, skilled trades, and food processing.
Founded in 1929 and headquartered in Cincinnati, Ohio, Cintas operates within the Diversified Support Services sub-industry of the Industrials sector. Its business model is built on a recurring rental and service subscription structure, which provides ongoing customer relationships and predictable revenue streams tied to contract durations.
- Uniform rental segment drives recurring revenue growth
- Workplace safety regulation boosts first aid services demand
- Acquisition strategy expands service offerings and geographic reach
| Net Income: 2.06b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.19 > 0.02 and ΔFCF/TA 1.85 > 1.0 |
| NWC/Revenue: 10.61% < 20% (prev 17.70%; Δ -7.08% < -1%) |
| CFO/TA 0.23 > 3% & CFO 2.43b > Net Income 2.06b |
| Net Debt (2.75b) to EBITDA (3.21b): 0.85 < 3 |
| Current Ratio: 1.45 > 1.5 & < 3 |
| Outstanding Shares: last quarter (404.3m) vs 12m ago -1.22% < -2% |
| Gross Margin: 50.99% > 18% (prev 50.10%; Δ 0.89% > 0.5%) |
| Asset Turnover: 112.8% > 50% (prev 107.3%; Δ 5.53% > 0%) |
| Interest Coverage Ratio: 25.28 > 6 (EBIT TTM 2.70b / Interest Expense TTM 106.8m) |
| A: 0.12 (Total Current Assets 3.93b - Total Current Liabilities 2.70b) / Total Assets 10.7b |
| B: 1.26 (Retained Earnings 13.4b / Total Assets 10.7b) |
| C: 0.26 (EBIT TTM 2.70b / Avg Total Assets 10.2b) |
| D: 0.96 (Book Value of Equity 5.20b / Total Liabilities 5.45b) |
| Altman-Z'' = 7.64 = AAA |
| DSRI: 1.02 (Receivables 1.59b/1.42b, Revenue 11.6b/10.6b) |
| GMI: 0.98 (GM 50.10% / 50.99%) |
| AQI: 0.95 (AQ_t 0.44 / AQ_t-1 0.46) |
| SGI: 1.10 (Revenue 11.6b / 10.6b) |
| TATA: -0.04 (NI 2.06b - CFO 2.43b) / TA 10.7b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of October 05, 2026, the stock is trading at USD 193.02 with a total of 1,858,015 shares traded. Over the past week, the price has changed by -3.45%, over one month by -2.56%, over three months by +6.70% and over the past year by -3.92%.
Current recommended Stop Loss: 188.00 (which is 2.6% or 1.3 ATR below the current price).
Cintas has received a consensus analysts rating of 3.80. Therefore, it is recommended to hold CTAS.
- StrongBuy: 8
- Buy: 2
- Hold: 9
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 218.3 | 13.1% |
P/E Trailing = 38.4283
P/E Forward = 36.2319
P/S = 6.7596
P/B = 15.4123
P/EG = 3.1404
Revenue TTM = 11.6b USD
EBIT TTM = 2.70b USD
EBITDA TTM = 3.21b USD
Long Term Debt = 1.43b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.06b USD (from shortTermDebt, last quarter)
Debt = 2.99b USD (from shortLongTermDebtTotal, last quarter) + Leases 277.9m
Net Debt = 2.75b USD (calculated: Debt 2.99b - CCE 243.6m)
Enterprise Value = 80.9b USD (78.1b + Debt 2.99b - CCE 243.6m)
Interest Coverage Ratio = 25.28 (Ebit TTM 2.70b / Interest Expense TTM 106.8m)
EV/FCF = 39.78x (Enterprise Value 80.9b / FCF TTM 2.03b)
FCF Yield = 2.51% (FCF TTM 2.03b / Enterprise Value 80.9b)
FCF Margin = 17.59% (FCF TTM 2.03b / Revenue TTM 11.6b)
Net Margin = 17.82% (Net Income TTM 2.06b / Revenue TTM 11.6b)
Gross Margin = 50.99% ((Revenue TTM 11.6b - Cost of Revenue TTM 5.67b) / Revenue TTM)
Gross Margin QoQ = 51.54% (prev 50.95%)
Tobins Q-Ratio = 7.59 (Enterprise Value 80.9b / Total Assets 10.7b)
Interest Expense / Debt = 3.57% (Interest Expense 106.8m / Debt 2.99b)
Taxrate = 20.73% (538.7m / 2.60b)
NOPAT = 2.14b (EBIT 2.70b * (1 - 20.73%))
Current Ratio = 1.45 (Total Current Assets 3.93b / Total Current Liabilities 2.70b)
Debt / Equity = 0.57 (Debt 2.99b / totalStockholderEquity, last quarter 5.20b)
Debt / EBITDA = 0.85 (Net Debt 2.75b / EBITDA 3.21b)
Debt / FCF = 1.35 (Net Debt 2.75b / FCF TTM 2.03b)
Total Stockholder Equity = 4.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 20.11% (Net Income 2.06b / Total Assets 10.7b)
RoE = 42.08% (Net Income TTM 2.06b / Total Stockholder Equity 4.90b)
RoCE = 42.69% (EBIT 2.70b / Capital Employed (Equity 4.90b + L.T.Debt 1.43b))
RoIC = 24.43% (NOPAT 2.14b / Invested Capital 8.76b)
WACC = 5.87% (E(78.1b)/V(81.1b) * Re(5.99%) + D(2.99b)/V(81.1b) * Rd(3.57%) * (1-Tc(0.21)))
Discount Rate = 5.99% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.15 | Cagr: -0.98%
[DCF] Terminal Value 77.97% ; FCFF base≈1.90b ; Y1≈2.18b ; Y5≈3.20b
[DCF] Fair Price = 113.8 (EV 48.2b - Net Debt 2.75b = Equity 45.5b / Shares 399.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -64.69 | EPS CAGR: -13.03% | SUE: 1.06 | # QB: 1
Revenue Correlation: 99.91 | Revenue CAGR: 8.48% | SUE: 1.93 | # QB: 5
EPS current Quarter (2026-11-30): EPS=1.36 | Chg30d=+0.89% | Revisions=-40% | Analysts=14
EPS next Quarter (2027-02-28): EPS=1.34 | Chg30d=-1.15% | Revisions=+0% | Analysts=14
EPS current Year (2027-05-31): EPS=5.54 | Chg30d=+0.77% | Revisions=+50% | GrowthEPS=+12.2% | GrowthRev=+8.7%
EPS next Year (2028-05-31): EPS=6.16 | Chg30d=+0.77% | Revisions=+50% | GrowthEPS=+11.2% | GrowthRev=+7.5%
[Analyst] Revisions Ratio: +31% (up=7, down=3)